Christian Schulze: Insights from DANGERSHOCK on Bleeding in IMPELLA Patients
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Bleeding events in IMPELLA patients are common and prognostically relevant.
In DANGERSHOCK, bleeding was associated with the complexity of MCS, with one-half of the bleeding events occurring after device removal.”
Title: Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy
Authors: Rikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, Christian Hassager, Hans Eiskjær, Norman Mangner, Amin Polzin, P. Christian Schulze, Carsten Skurk, Peter Nordbeck, Peter Clemmensen, Vasileios Panoulas, Sebastian Zimmer, Andreas Schäfer, Steffen Christensen, Thomas Engstrøm, Rasmus Paulin Beske, Martin Frydland, Lisette Okkels Jensen, Anders Junker, Henrik Schmidt, Nanna Louise Junker Udesen, Christian Juhl Terkelsen, Axel Linke, Lene Holmvang, the DanGer Shock Investigators
Read the Full Article on JACC: Cardiovascular Interventions

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa
-
Nov 14, 2026, 14:19Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management
-
Nov 14, 2026, 14:14Expanding Global Access to Gene Therapy – WFH